Search results
Information for you. Featured news and updates for patients and carers. Featured news and updates for healthcare professionals, including doctors, nurses and pharmacists. Featured news and updates for animal health professionals and users of veterinary medicines such as pet owners.
The European Medicines Agency (EMA) facilitates development and access to medicines for countries within the European Union (EU). EMA evaluates applications for marketing authorisation submitted via the centralised procedure, monitors the safety of medicines across their lifecycle and provides information to healthcare professionals and patients.
The European Medicines Agency (EMA) protects and promotes human and animal health by evaluating and monitoring medicines within the European Union (EU) and the European Economic Area (EEA). What it does. The Agency's main responsibilities are authorising and monitoring medicines in the EU.
The mission of the European Medicines Agency (EMA) is to foster scientific excellence in the evaluation and supervision of medicines, for the benefit of public and animal health in the European Union (EU).
The European Medicines Agency (EMA) is an agency of the European Union (EU) in charge of the evaluation and supervision of pharmaceutical products. Prior to 2004, it was known as the European Agency for the Evaluation of Medicinal Products or European Medicines Evaluation Agency ( EMEA ).
EMA Account Management is the European Medicines Agency’s (EMA) secure online platform where you can request and manage access to EMA applications. You can use the EMA Account Management portal to: Create an EMA account (Self-Register) Self-service Registration form here. Note:
Nov 30, 2021 · The EU is prepared to tackle ongoing pandemic challenges, says EMA chief. Health MEPs quizzed the EMA’s Executive Director on Tuesday on the current situation around COVID-19 vaccines and therapeutics, as well as the Agency’s future role.
What is Exponential Moving Average. An exponential moving average (EMA) is a widely used technical chart indicator that tracks changes in the price of a financial instrument over a certain period. Unlike simple moving average (SMA), EMA puts more emphasis on recent data points like the latest prices.
The HMA-EMA Catalogues are repositories of metadata collected from real-world data (RWD) sources and RWD studies. They are intended to help regulators, pharmaceutical companies and researchers to identify and use such data when investigating the use, safety and effectiveness of medicines.
EMA is the first regulatory authority worldwide to provide such broad access to clinical data. For more information on the clinical data on this website, see Clinical data available. For more information on EMA and its policy on the publication of clinical data, see the EMA corporate website.
